Business Acquisition (Tables)

12 Months Ended

Dec. 31, 2015

MDV3800 [Member]

Summary of Final Allocation of Purchase Consideration, Including Contingent Consideration Payable, Based on Fair Value

The following table presents the final allocation of the purchase consideration for the MDV3800 acquisition, including the contingent consideration payable, based on fair value:

Purchase consideration:
Cash	$	410,000
Acquisition-date fair value of contingent consideration		171,942
Total purchase consideration	$	581,942
Allocation of the purchase consideration:
Assets:
Identifiable intangible assets- IPR&D	$	573,299
Net identifiable assets acquired		573,299
Goodwill		8,643
Net assets acquired	$	581,942

Summary of Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations of Medivation and MDV3800 as if the acquisition of MDV3800 had been completed on January 1, 2014, with adjustments to give effect to pro forma events that are directly attributable to the acquisition. The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the operations of Medivation and MDV3800. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations:

	Year Ended December 31,
	2015		2014
Total revenues	$	943,258	$	710,487
Net income	$	201,161	$	230,271

MDV9300 [Member]

Summary of Final Allocation of Purchase Consideration, Including Contingent Consideration Payable, Based on Fair Value

The following table presents the final allocation of the purchase consideration for the MDV9300 acquisition, including the contingent consideration payable, based on fair value:

Purchase consideration:
Cash	$	5,000
Acquisition-date fair value of contingent consideration		106,000
Total purchase consideration	$	111,000
Allocation of the purchase consideration:
Assets:
Identifiable intangible assets- IPR&D	$	101,000
Net identifiable assets acquired		101,000
Goodwill		10,000
Net assets acquired	$	111,000

Summary of Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations of Medivation and MDV9300 as if the acquisition of MDV9300 had been completed on January 1, 2013, with adjustments to give effect to pro forma events that are directly attributable to the acquisition. The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the operations of Medivation and MDV9300. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations:

	Year Ended December 31,
	2014		2013
Total revenues	$	710,487	$	272,942
Net income (loss)	$	274,626	$	(45,685	)